Liquid chromatographic assay for the simultaneous determination of indole-3-carbinol and its acid condensation products in plasma

被引:45
作者
Anderton, MJ
Jukes, R
Lamb, JH
Manson, MM
Gescher, A
Steward, WP
Williams, ML
机构
[1] NIA, NIH, Gerontol Res Ctr, Bioanalyt & Drug Discovery Unit, Baltimore, MD 21224 USA
[2] Univ Leicester, Leicester Royal Infirm, Dept Oncol, Leicester LE2 7LX, Leics, England
[3] MRC, Toxicol Unit, Leicester, Leics, England
[4] Univ Leicester, Bioctr, Dept Biochem, Leicester LE1 7RH, Leics, England
[5] Univ Leicester, Bioctr, Dept Oncol, Leicester LE1 7RH, Leics, England
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 787卷 / 02期
关键词
indole-3-carbinol; 3,3 '-diindolylmethane;
D O I
10.1016/S1570-0232(02)00923-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high-performance liquid chromatographic method was developed for the simultaneous determination of indole-3-carbinol (I3C), 3,3' diindolylmethane (DIM), [2-(indol-3-ylmethyl)-indol-3-yl]indol-3-ylmethane (LTr1), and indolo[3,2b]carbazole (ICZ). Compounds were extracted from mouse plasma using tert.-butyl methyl ether, incorporating 4-methoxy-indole as internal standard. Chromatographic separation utilized a Waters Symmetry RP18 in tandem with a Thermoquest BDS C-18 column, an acetonitrile-water gradient and UV (280 nm) in series with fluorescence (ex. 335 nm; em. 415 nm) detection. Calibration curves were linear (r(2>)0.99) between 50 and 15,000 ng/ml for I3C; 150 and 15,000 ng/ml for LTr1; and 0.15 and 37.5 ng/ml for ICZ and the method was reproducible and precise (within-day and between-day coefficients of variation below 9.7 and 13%, respectively). The method described is suitable for comprehensive pharmacokinetic studies with indole-3-carbinol. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:281 / 291
页数:11
相关论文
共 24 条
[1]  
ARNESON DW, 2000, P AM ASSOC CANC RES, P868
[2]   Placebo-controlled trial of indole-3-carbinol in the treatment of CIN [J].
Bell, MC ;
Crowley-Nowick, P ;
Bradlow, HL ;
Sepkovic, DW ;
Schmidt-Grimminger, D ;
Howell, P ;
Mayeaux, EJ ;
Tucker, A ;
Turbat-Herrera, EA ;
Mathis, JM .
GYNECOLOGIC ONCOLOGY, 2000, 78 (02) :123-129
[3]   AROMATIC HYDROCARBON RESPONSIVENESS-RECEPTOR AGONISTS GENERATED FROM INDOLE-3-CARBINOL INVITRO AND INVIVO - COMPARISONS WITH 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN [J].
BJELDANES, LF ;
KIM, JY ;
GROSE, KR ;
BARTHOLOMEW, JC ;
BRADFIELD, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9543-9547
[4]   Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3′-diindolylmethane, a major in vivo product of dietary indole-3-carbinol [J].
Chang, YC ;
Riby, J ;
Chang, GHF ;
Peng, BC ;
Firestone, G ;
Bjeldanes, LF .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (05) :825-834
[5]   Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane [J].
Chen, I ;
McDougal, A ;
Wang, F ;
Safe, S .
CARCINOGENESIS, 1998, 19 (09) :1631-1639
[6]   INVIVO DISPOSITION OF THE NATURAL ANTI-CARCINOGEN INDOLE-3-CARBINOL AFTER PO ADMINISTRATION TO RAINBOW-TROUT [J].
DASHWOOD, RH ;
UYETAKE, L ;
FONG, AT ;
HENDRICKS, JD ;
BAILEY, GS .
FOOD AND CHEMICAL TOXICOLOGY, 1989, 27 (06) :385-392
[7]   STRUCTURE ELUCIDATION OF ACID REACTION-PRODUCTS OF INDOLE-3-CARBINOL - DETECTION INVIVO AND ENZYME-INDUCTION INVITRO [J].
DEKRUIF, CA ;
MARSMAN, JW ;
VENEKAMP, JC ;
FALKE, HE ;
NOORDHOEK, J ;
BLAAUBOER, BJ ;
WORTELBOER, HM .
CHEMICO-BIOLOGICAL INTERACTIONS, 1991, 80 (03) :303-315
[8]  
FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219
[9]  
Ge XK, 1999, ANTICANCER RES, V19, P3199
[10]   OLIGOMERIZATION OF INDOLE-3-CARBINOL IN AQUEOUS ACID [J].
GROSE, KR ;
BJELDANES, LF .
CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (02) :188-193